Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000038789 | SCV000062467 | likely benign | not specified | 2015-12-14 | criteria provided, single submitter | clinical testing | p.Val391Ile in exon 9B of LAMP2: This variant is not expected to have clinical s ignificance because it has been identified in 0.6% (294/47993) of European chrom osomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org ; dbSNP rs144140265). |
Gene |
RCV000038789 | SCV000170073 | benign | not specified | 2012-04-30 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000230647 | SCV000287341 | benign | Danon disease | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000431687 | SCV000510645 | benign | not provided | 2016-09-20 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000038789 | SCV000740587 | likely benign | not specified | 2016-07-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000431687 | SCV001150435 | uncertain significance | not provided | 2016-06-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002326744 | SCV002629809 | benign | Cardiovascular phenotype | 2017-10-13 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Molecular Genetics, |
RCV000230647 | SCV004812745 | likely benign | Danon disease | 2023-10-06 | criteria provided, single submitter | clinical testing | |
Stanford Center for Inherited Cardiovascular Disease, |
RCV000038789 | SCV000280173 | benign | not specified | 2011-03-28 | no assertion criteria provided | clinical testing | Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease |
Diagnostic Laboratory, |
RCV000230647 | SCV000734730 | likely benign | Danon disease | no assertion criteria provided | clinical testing | ||
Mayo Clinic Laboratories, |
RCV000431687 | SCV000801129 | benign | not provided | 2017-08-16 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV000038789 | SCV001920354 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000431687 | SCV001932061 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000038789 | SCV001958632 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000038789 | SCV001966336 | benign | not specified | no assertion criteria provided | clinical testing | ||
Cohesion Phenomics | RCV003125866 | SCV003803625 | likely benign | Hypertrophic cardiomyopathy | 2022-09-29 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003924937 | SCV004743661 | benign | LAMP2-related disorder | 2019-05-20 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |